Diseases, Conditions, Syndromes

A roadmap for the future of hepatitis B therapy development

Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...

Diseases, Conditions, Syndromes

Review shines a light on the overlooked virus, hepatitis D

Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is another, less commonly known ...

Diseases, Conditions, Syndromes

When to get a COVID-19 booster

If you recently had COVID-19, you may be wondering if you should delay getting your booster. We asked James Moy, MD, an immunologist in the Department of Internal Medicine at RUSH who is studying the antibody levels and duration ...

Diseases, Conditions, Syndromes

Universal HepB vaccination recommended for adults age 19 to 59

Hepatitis B (HepB) vaccination should be administered to adults aged 19 to 59 years and to those aged 60 years or older with risk factors for HepB, according to updated recommendations published in the April 1 issue of the ...

page 6 from 36